|
1.
|
Strojan P, Ferlito A, Medina JE, et al:
Contemporary management of lymph node metastases from an unknown
primary to the neck: I. A review of diagnostic approaches. Head
Neck. 35:123–132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Gervasoni A, Sandri MT, Nascimbeni R, et
al: Comparison of three distinct methods for the detection of
circulating tumor cells in colorectal cancer patients. Oncol Rep.
25:1669–1703. 2011.PubMed/NCBI
|
|
3.
|
Strojan P, Ferlito A, Langendijk JA, et
al: Contemporary management of lymph node metastases from an
unknown primary to the neck: II. a review of therapeutic options.
Head Neck. 35:286–293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Haas I, Hoffmann TK, Engers R and Ganzer
U: Diagnostic strategies in cervical carcinoma of an unknown
primary (CUP). Eur Arch Otorhinolaryngol. 259:325–333.
2002.PubMed/NCBI
|
|
5.
|
Giridharan W, Hughes J, Fenton JE and
Jones AS: Lymph node metastases in the lower neck. Clin Otolaryngol
Allied Sci. 28:221–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Chepeha D, Koch W and Pitman K: Management
of unknown primary tumor. Head Neck. 25:499–504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Cerezo L, Raboso E and Ballesteros AI:
Unknown primary cancer of the head and neck: a multidisciplinary
approach. Clin Transl Oncol. 13:88–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Oien KA: Pathologic evaluation of unknown
primary cancer. Semin Oncol. 36:8–37. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
van de Stolpe A, Pantel K, Sleijfer S,
Terstappen LW and den Toonder JM: Circulating tumor cell isolation
and diagnostics: toward routine clinical use. Cancer Res.
71:5955–5960. 2011.PubMed/NCBI
|
|
10.
|
Pantel K, Brakenhoff RH and Brandt B:
Detection, clinical relevance and specific biological properties of
disseminating tumour cells. Nat Rev Cancer. 8:329–340. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Smirnov DA, Foulk BW, Doyle GV, Connelly
MC, Terstappen LW and O’Hara SM: Global gene expression profiling
of circulating endothelial cells in patients with metastatic
carcinomas. Cancer Research. 66:2918–2922. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Marrinucci D, Bethel K, Bruce RH, et al:
Case study of the morphologic variation of circulating tumor cells.
Human Pathol. 38:514–519. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Bellone S, Siegel ER, Cocco E, et al:
Overexpression of epithelial cell adhesion molecule in primary,
metastatic, and recurrent/chemotherapy-resistant epithelial ovarian
cancer: implications for epithelial cell adhesion molecule-specific
immunotherapy. Int J Gynecol Cancer. 19:860–866. 2009. View Article : Google Scholar
|
|
14.
|
Shim HS, Yoon BS and Cho NH: Prognostic
significance of paired epithelial cell adhesion molecule and
E-cadherin in ovarian serous carcinoma. Human Pathol. 40:693–698.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Miller MC, Doyle GV and Terstappen LW:
Significance of circulating tumor cells detected by the CellSearch
system in patients with metastatic breast colorectal and prostate
cancer. J Oncol. 2010:6174212010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Poveda A, Kaye SB, McCormack R, et al:
Circulating tumor cells predict progression free survival and
overall survival in patients with relapsed/recurrent advanced
ovarian cancer. Gynecol Oncol. 122:567–572. 2011. View Article : Google Scholar
|
|
17.
|
Rusthoven KE, Koshy M and Paulino AC: The
role of fluorodeoxyglucose positron emission tomography in cervical
lymph node metastases from an unknown primary tumor. Cancer.
101:2641–2649. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kwee TC and Kwee RM: Combined FDG-PET/CT
for the detection of unknown primary tumors: systematic review and
meta-analysis. Eur Radiol. 19:731–744. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Al-Ibraheem A, Buck A, Krause BJ,
Scheidhauer K and Schwaiger M: Clinical applications of FDG PET and
PET/CT in head and neck cancer. J Oncol. 2009:2087252009.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Fanti S, Nanni C, Castellucci P, et al:
Supra-clavicular lymph node metastatic spread in patients with
ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding.
Cancer Imaging. 6:20–23. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Dvoretsky PM, Richards KA, Angel C, et al:
Distribution of disease at autopsy in 100 women with ovarian
cancer. Hum Pathol. 19:57–63. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Euscher ED, Silva EG, Deavers MT, Elishaev
E, Gershenson DM and Malpica A: Serous carcinoma of the ovary,
fallopian tube, or peritoneum presenting as lymphadenopathy. Am J
Surg Pathol. 28:1217–1223. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Moll R, Löwe A, Laufer J and Franke WW:
Cytokeratin 20 in human carcinomas. A new histodiagnostic marker
detected by monoclonal antibodies. Am J Pathol. 140:427–447.
1992.PubMed/NCBI
|
|
24.
|
Rubin BP, Skarin AT, Pisick E, Rizk M and
Salgia R: Use of cytokeratins 7 and 20 in determining the origin of
metastatic carcinoma of unknown primary, with special emphasis on
lung cancer. Eur J Cancer Prev. 10:77–82. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Roh MS and Hong SH: Utility of thyroid
transcription factor-1 and cytokeratin 20 in identifying the origin
of metastatic carcinomas of cervical lymph nodes. J Korean Med Sci.
17:512–517. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Kaufmann O, Deidesheimer T, Muehlenberg M,
Deicke P and Dietel M: Immunohistochemical differentiation of
metastatic breast carcinomas from metastatic adenocarcinomas of
other common primary sites. Histopathology. 29:233–240. 1996.
View Article : Google Scholar
|
|
27.
|
Mittal K, Soslow R and McCluggage WG:
Application of immunohistochemistry to gynecologic pathology. Arch
Pathol Lab Med. 132:402–423. 2008.PubMed/NCBI
|
|
28.
|
Acs G, Pasha T and Zhang PJ: WT1 is
differentially expressed in serous, endometrioid, clear cell, and
mucinous carcinomas of the peritoneum, fallopian tube, ovary, and
endometrium. Int J Gynecol Pathol. 23:110–118. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Malpica A, Deavers MT, Gershenson D,
Tortolero-Luna G and Silva EG: Serous tumors involving
extra-abdominal/extra-pelvic sites after the diagnosis of an
ovarian serous neoplasm of low malignant potential. Am J Surg
Pathol. 25:988–996. 2001. View Article : Google Scholar
|
|
30.
|
Verbruggen MB, Verheijen RH, van de Goot
FR, van Beurden M, Dorsman JC and van Diest PJ: Serous borderline
tumor of the ovary presenting with cervical lymph node involvement:
a report of 3 cases. Am J Surg Pathol. 30:739–743. 2006. View Article : Google Scholar : PubMed/NCBI
|
